跳至主要内容
临床试验/JPRN-UMIN000005678
JPRN-UMIN000005678已完成未知

Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinoma - Hepatic arterial infusion chemotherapy with MRP3-derived peptide for hepatocellular carcinoma

Department of Gastroenterology, Kanazawa University Hospital0 个研究点目标入组 12 人开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Severe complications associated with heart, kidney, lung, blood and coagulability 2)Infection of HIV 3)Past medical history of malignancy 4)Surgical treatment, chemotherapy and radiation therrapy within 4 weeks 5)Past medical history of Immunodeficiency, splenectomy and radiation of spleen 6)medical treatments with steroid 7)Patients who are during lactation 8)Patients who are during pregnancy and expected pregnancy 9)Past history of organ transplantation 10)Patients who are predicted a difficulty of following clinical course 11)Patients who are judged inappropriate for clinical trial

研究者

发起方
Department of Gastroenterology, Kanazawa University Hospital

相似试验